β 3 Adrenergic agonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S121000

Reexamination Certificate

active

07071208

ABSTRACT:
The present invention relates to a β3adrenergic receptor agonist of formula (I) or a pharmaceutical salt thereof; useful for treating Type II diabetes and/or obesity.

REFERENCES:
patent: 4276304 (1981-06-01), Ikezaki et al.
patent: 4826847 (1989-05-01), Michel et al.
patent: 5808080 (1998-09-01), Bell et al.
patent: 6011048 (2000-01-01), Mathvink et al.
patent: 2830884 (1979-01-01), None
patent: 166331 (1986-01-01), None
patent: 221414 (1987-05-01), None
patent: 236624 (1987-09-01), None
patent: 611003 (1994-08-01), None
patent: 678511 (1995-10-01), None
patent: 764640 (1997-03-01), None
patent: 1549945 (1979-08-01), None
patent: WO 95/29159 (1995-11-01), None
patent: WO 97/10825 (1997-03-01), None
patent: WO 97/46556 (1997-12-01), None
patent: WO 98/4526 (1998-02-01), None
patent: WO 98/9625 (1998-03-01), None
patent: WO 98/32753 (1998-07-01), None
patent: WO 00/40560 (2000-07-01), None
patent: WO 00/44721 (2000-08-01), None
patent: WO 01/7026 (2001-02-01), None
patent: WO 01/35947 (2001-05-01), None
patent: WO 01/36412 (2001-05-01), None
patent: WO 01/53298 (2001-07-01), None
patent: WO 02/6276 (2002-01-01), None
patent: WO 02/38543 (2002-05-01), None
patent: WO 03/16276 (2003-02-01), None
patent: WO 03/16307 (2003-02-01), None
Weber A E, et al;Bioorganic&Medicinal Chemistry Letters; 8(16):2111-2116, 1998.
Shuker A J, et al;Tetrahedron Letters; 38(35, Sep. 1, 1997; pp. 6149-6152.
Weber A E, et al; Bioorganic & Medicinal Chemistry Letters; 8(9):1101-1106, 1998.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

β 3 Adrenergic agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with β 3 Adrenergic agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and β 3 Adrenergic agonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3579989

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.